Literature DB >> 16596183

Expression profile of N-cadherin differs from other classical cadherins as a prognostic marker in renal cell carcinoma.

Toru Shimazui1, Takahiro Kojima, Mizuki Onozawa, Masahiko Suzuki, Taeko Asano, Hideyuki Akaza.   

Abstract

Renal cell carcinomas (RCCs) primarily express cadherin-6 and N-cadherin rather than E-cadherin, and the aberrant expression of cadherin-6 correlates with a poor prognosis in patients with E-cadherin-absent RCC. However, the role of N-cadherin in RCC has not yet been elucidated. In this study, we analyze the expression pattern of N-cadherin in surgical RCC specimens and discuss the function of N-cadherin in RCC together with a re-evaluation of our previous study. Forty-six surgically resected RCC specimens were used in this study. The expression and localization of E-cadherin and N-cadherin in surgical specimens were demonstrated by immunohistochemistry. Correlations between the expression pattern of each cadherin, pathological parameters and patient survival were analyzed. RCC specimens expressed N-cadherin as a normal pattern despite the elevation of tumor grade, and patients with N-cadherin-normal RCC had a poorer prognosis than those with N-cadherin-abnormal RCC. Since our previous study showed that N-cadherin only functioned in cell attachment when E-cadherin and cadherin-6 were impaired, N-cadherin plays a different role from E-cadherin or cadherin-6 in RCC and may be associated with the aggressiveness and malignant potential of RCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16596183

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  13 in total

1.  Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.

Authors:  Darue A Prieto; Donald J Johann; Bih-Rong Wei; Xiaoying Ye; King C Chan; Dwight V Nissley; R Mark Simpson; Deborah E Citrin; Crystal L Mackall; W Marston Linehan; Josip Blonder
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

2.  Differential expression in clear cell renal cell carcinoma identified by gene expression profiling.

Authors:  Brian R Lane; Jianbo Li; Ming Zhou; Denise Babineau; Pieter Faber; Andrew C Novick; Bryan R G Williams
Journal:  J Urol       Date:  2008-12-17       Impact factor: 7.450

3.  A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease.

Authors:  Masahiro Yanagisawa; Deborah Huveldt; Pamela Kreinest; Christine M Lohse; John C Cheville; Alexander S Parker; John A Copland; Panos Z Anastasiadis
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

4.  Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells.

Authors:  Sanjai K Addla; Mick D Brown; Claire A Hart; Vijay A C Ramani; Noel W Clarke
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-09

5.  Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.

Authors:  Yasuo Awakura; Eijiro Nakamura; Takeshi Takahashi; Hirokazu Kotani; Yoshiki Mikami; Tadashi Kadowaki; Akira Myoumoto; Hideo Akiyama; Noriyuki Ito; Toshiyuki Kamoto; Toshiaki Manabe; Hitoshi Nobumasa; Gozoh Tsujimoto; Osamu Ogawa
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-16       Impact factor: 4.553

6.  Genomic events associated with progression of pleural malignant mesothelioma.

Authors:  Sergey V Ivanov; Jeremy Miller; Robert Lucito; Chunlao Tang; Alla V Ivanova; Jianming Pei; Michele Carbone; Christina Cruz; Amanda Beck; Craig Webb; Daisuke Nonaka; Joseph R Testa; Harvey I Pass
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

7.  Cadherin expression, vectorial active transport, and metallothionein isoform 3 mediated EMT/MET responses in cultured primary and immortalized human proximal tubule cells.

Authors:  Andrea Slusser; Chandra S Bathula; Donald A Sens; Seema Somji; Mary Ann Sens; Xu Dong Zhou; Scott H Garrett
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

8.  Distinct mesenchymal alterations in N-cadherin and E-cadherin positive primary renal epithelial cells.

Authors:  Christof Keller; Sven Kroening; Jonathan Zuehlke; Frank Kunath; Bettina Krueger; Margarete Goppelt-Struebe
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

9.  Cadherin-12 contributes to tumorigenicity in colorectal cancer by promoting migration, invasion, adhersion and angiogenesis.

Authors:  Jingkun Zhao; Pu Li; Hao Feng; Puxiongzhi Wang; Yaping Zong; Junjun Ma; Zhuo Zhang; Xuehua Chen; Minhua Zheng; Zhenggang Zhu; Aiguo Lu
Journal:  J Transl Med       Date:  2013-11-15       Impact factor: 5.531

10.  Pathway landscapes and epigenetic regulation in breast cancer and melanoma cell lines.

Authors:  Mariama El Baroudi; Dario La Sala; Caterina Cinti; Enrico Capobianco
Journal:  Theor Biol Med Model       Date:  2014-05-07       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.